yttrium clivatuzumab tetraxetan trade name humanized monoclonal antibodydrug conjugate designed treatment pancreatic antibody part clivatuzumab targeted conjugated tetraxetan chelator radioisotope destroys tumour cells drug developed immunomedics inc march phase iii trial metastatic pancreatic cancer terminated early due lack improvement overall nuclear medicine article stub help wikipedia expanding monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding